biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
NEWS
15.02.2021
Scope Fluids has finished preregistration tests on the SARS Cov-2 panel
READ MORE
13.01.2021
Scope Fluidics has commenced the verification of the BacterOMIC system, which is one of the elements of the preregistration procedure
READ MORE
16.12.2020
Scope Fluidics obtains another European patent protecting the BacterOMIC technology
READ MORE
16.11.2020
Scope Fluidics successfully issues shares and secures the financing for its flagship project
READ MORE
28.10.2020
Prof. Prof. Carl Wittwer – the legendary creator of the PCR technology joins the Scope Fluidics Advisory Committee
READ MORE
12.10.2020
Scope Fluidics launches clinical tests of the PCR|ONE SARS-Cov-2 panel in the clinical environment
READ MORE
04.10.2020
Scope Fluidics launches a manufacturing line for the Bacteromic system
READ MORE
30.09.2020
Scope Fluidics intends to enter the Warsaw Stock Exchange regulated market in 2021
READ MORE
29.09.2020
Scope Fluidics implements mass production of PCR|ONE system which detects bacterial and viral infections in 15 minutes
READ MORE
1
…
3
4
5
6
7
…
11